{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:08:06Z","timestamp":1790197686500,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301654"],"award-info":[{"award-number":["82301654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0536"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0536"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.yebeh.2026.110898","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:20:02Z","timestamp":1770070802000},"page":"110898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy differences between tocilizumab and ketogenic diet during acute phase of febrile Infection-Related epilepsy syndrome in children: A retrospective cohort study"],"prefix":"10.1016","volume":"177","author":[{"given":"Xinru","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-9182","authenticated-orcid":false,"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2026.110898_b0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110898_b0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110898_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.26815\/acn.2019.00283","article-title":"Refractory status epilepticus and management strategies","volume":"28","author":"Lee","year":"2020","journal-title":"Ann Child Neurol"},{"key":"10.1016\/j.yebeh.2026.110898_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2023.09.008","article-title":"Febrile infection-related epilepsy syndrome in childhood: A clinical review and practical approach","volume":"111","author":"van Baalen","year":"2023","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2026.110898_b0025","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110898_b0030","series-title":"Febrile Infection-Related Epilepsy Syndrome (FIRES): Statements and Supporting Evidence.Epilepsia. Published online August 23","article-title":"International consensus recommendations for management of new onset refractory status epilepticus (NORSE) incl","author":"Wickstrom","year":"2022"},{"issue":"18","key":"10.1016\/j.yebeh.2026.110898_b0035","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: Etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.yebeh.2026.110898_b0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110898_b0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.26627","article-title":"Cytokines in new-onset refractory status epilepticus predict outcomes","volume":"94","author":"Hanin","year":"2023","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2026.110898_b0050","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.yebeh.2026.110898_b0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"10.1016\/j.yebeh.2026.110898_b0060","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/epi.13801","article-title":"Early ictal and interictal patterns in FIRES: The sparks before the blaze","volume":"58","author":"Farias-Moeller","year":"2017","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2026.110898_b0065","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2026.110898_b0070","doi-asserted-by":"crossref","unstructured":"Wickstrom R, Taraschenko O, Dilena R, et al. International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) including Febrile Infection-Related Epilepsy Syndrome (FIRES): Summary and Clinical Tools.Epilepsia. Published online August 11, 2022.","DOI":"10.1111\/epi.17391"},{"issue":"5","key":"10.1016\/j.yebeh.2026.110898_b0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/epi.17933","article-title":"Second-line immunotherapy in new onset refractory status epilepticus","volume":"65","author":"Hanin","year":"2024","journal-title":"Epilepsia"},{"issue":"24","key":"10.1016\/j.yebeh.2026.110898_b0080","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1212\/WNL.0000000000207068","article-title":"Bridging the gap: Tailoring an approach to treatment in febrile infection-related epilepsy syndrome","volume":"100","author":"Goh","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.110898_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106454","article-title":"Ketogenic diet and Neuroinflammation","volume":"167","author":"Koh","year":"2020","journal-title":"Epilepsy Res"},{"issue":"11","key":"10.1016\/j.yebeh.2026.110898_b0090","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children","volume":"52","author":"Kramer","year":"2011","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110898_b0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00415-025-13032-0","article-title":"Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2","volume":"272","author":"Rittel","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2026.110898_b0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.110898_b0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10309-022-00533-5","article-title":"FIRES\u2014Pathophysiology, therapeutical approach, and outcome","volume":"35","author":"Reppucci","year":"2022","journal-title":"Z Epileptol"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110898_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/epi4.12447","article-title":"Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop","volume":"6","author":"Koh","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.110898_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1134827","article-title":"Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data","volume":"14","author":"Nabbout","year":"2023","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110898_b0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/epi.13750","article-title":"Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury","volume":"58","author":"Gallentine","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110898_b0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200259","article-title":"Single-cell transcriptomic analyses of brain parenchyma in patients with new-onset refractory status epilepticus (NORSE)","volume":"11","author":"Hanin","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110898_b0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1474-4422(10)70214-3","article-title":"Acute encephalopathy with inflammation-mediated status epilepticus","volume":"10","author":"Nabbout","year":"2011","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2026.110898_b0135","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1007\/s00415-023-11726-x","article-title":"Neuropathology of new-onset refractory status epilepticus (NORSE)","volume":"270","author":"Hanin","year":"2023","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2026.110898_b0140","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s12035-022-02725-6","article-title":"Neuroinflammation and proinflammatory cytokines in epileptogenesis","volume":"59","author":"Soltani Khaboushan","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2026.110898_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105468","article-title":"CXCL1-CXCR1\/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy","volume":"158","author":"Di Sapia","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110898_b0220","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110898_b0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2032911","article-title":"Tocilizumab in Covid-19","volume":"384","author":"Leaf","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2026.110898_b0155","doi-asserted-by":"crossref","unstructured":"Cytokine Storm Drugs Move from CAR T to COVID-19.Cancer Discov. 2020,10(7):OF8.","DOI":"10.1158\/2159-8290.CD-ND2020-008"},{"issue":"12","key":"10.1016\/j.yebeh.2026.110898_b0225","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: An international cohort","volume":"7","author":"Lai","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2026.110898_b0160","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamapediatrics.2020.2282","article-title":"Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: A randomized clinical trial","volume":"174","author":"Sondhi","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.yebeh.2026.110898_b0165","first-page":"741","volume":"44","author":"Dahlin","year":"2019","journal-title":"The gut microbiome and epilepsy EBioMedicine"},{"key":"10.1016\/j.yebeh.2026.110898_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105400","article-title":"Association between seizure reduction during ketogenic diet treatment of epilepsy and changes in circulatory metabolites and gut microbiota composition","volume":"109","author":"Dahlin","year":"2024","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110898_b0175","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110898_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13668-022-00405-4","article-title":"The efficacy and safety of ketogenic diets in drug-resistant epilepsy in children and adolescents: A systematic review of randomized controlled trials","volume":"11","author":"Desli","year":"2022","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.yebeh.2026.110898_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eplepsyres.2018.09.002","article-title":"Use of cooking oils in a 2:1 ratio classical ketogenic diet for intractable pediatric epilepsy: Long-term effectiveness and tolerability","volume":"147","author":"Lee","year":"2018","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110898_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061809","article-title":"Efficacy and safety of a ketogenic diet in children and adolescents with refractory epilepsy-a review","volume":"12","author":"Wells","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110898_b0190","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1189\/jlb.1211601","article-title":"Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus","volume":"92","author":"Parker","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.yebeh.2026.110898_b0195","doi-asserted-by":"crossref","unstructured":"Cicco S, Cicco G, Racanelli V, Vacca A. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.Mediators Inflamm. 2020,2020:7527953. Published 2020 Jul 16.","DOI":"10.1155\/2020\/7527953"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110898_b0200","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40121-023-00813-1","article-title":"Dynamic NLR and PLR in predicting COVID-19 severity: A retrospective cohort study","volume":"12","author":"Asperges","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.yebeh.2026.110898_b0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.wneu.2020.04.185","article-title":"Neutrophil-to-lymphocyte ratio and traumatic brain injury: A review study","volume":"140","author":"Sabouri","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.yebeh.2026.110898_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577142","article-title":"Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients","volume":"340","author":"Cantar\u00edn-Extremera","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110898_b0215","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/epi.17591","article-title":"Treatment of new onset refractory status epilepticus\/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult","volume":"64","author":"Girardin","year":"2023","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:28:09Z","timestamp":1771950489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"alternative-id":["S1525505026000193"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110898","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy differences between tocilizumab and ketogenic diet during acute phase of febrile Infection-Related epilepsy syndrome in children: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110898"}}